|
MechanismROCK1 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with deVGen NV
0 Patents (Medical) associated with deVGen NV
100 Deals associated with deVGen NV
100 Translational Medicine associated with deVGen NV